NCT06357819View on ClinicalTrials.gov

INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation

CompletedOBSERVATIONAL
Enrollment

405

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

December 17, 2023

Study Completion Date

December 17, 2023

Conditions
Hepatitis C
Interventions
DEVICE

INSTI HCV Self Test

Each participant was provided with contrived INSTI membrane units by the study observer, in random order, and was asked to interpret the results using the INSTI HCV ST Instructions for Use.

Trial Locations (1)

V6V 2A2

bioLytical Laboratories Inc., Richmond

Sponsors
All Listed Sponsors
lead

bioLytical Laboratories

INDUSTRY